Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 November 2024 | Story Leonie Bolleurs | Photo Tania Allen
Business School Partnership 2024
Prof Per Assmo from University West, Sweden and Prof Anthea Rhoda from the UFS signed a Memorandum of Understanding that will develop academic cooperation across fields such as research, student and academic exchanges, and collaborative projects.

The University of the Free State (UFS) has signed a Memorandum of Understanding (MOU) with University West, Sweden. Held at the UFS Business School on the Bloemfontein Campus, the event saw the signing of the agreement by Prof Anthea Rhoda, acting UFS Vice-Chancellor and Principal, and Prof Per Assmo, Deputy Vice-Chancellor for Internationalisation at University West. The partnership aims to develop academic cooperation across fields such as research, student and academic exchanges, and collaborative projects.

This MOU opens the door to a wide range of collaborative initiatives, including academic and researcher exchanges for the purposes of teaching, conducting lectures, conducting research, and exchanging expertise. Additionally, the MOU includes student exchange programmes, joint research projects, and the shared hosting of seminars and conferences.

Prof Rhoda shared her enthusiasm to incorporate work-integrated learning (WIL) more widely at the UFS. “We are looking at work-integrated learning as an extension of engaged scholarship. It is something that we're looking forward to expanding,” she said.

Building a connected community

Prof Assmo explained that their institution, though small, has a unique approach that focuses on both production technology and work-integrated learning – a teaching model that goes beyond internships to provide students with practical, hands-on experience. "For us, WIL is a research field and academic discipline in its own right," he said.

University West is also the only university in the world to offer a PhD specifically in WIL, a programme it spent 20 years developing.

“We want to collaborate with South Africa as a strategic partner,” he said. The University West is already actively working with several South African universities, including the UFS, the Central University of Technology, the University of the Western Cape, and Tshwane University of Technology. “This would be the core for us, where we collaborate and find different forms within research and education, not restricted to any faculty or field as such.”

His vision also includes forming a larger ‘Nordic hub’ of connections across Sweden, Norway, and the European Union, along with a ‘regional hub’ in Bloemfontein. This way, universities can share ideas and resources to build a stronger, more connected community for the future.

A need for work-integrated learning

A working example of this partnership between University West and the UFS is the collaborative focus on integrated learning between Prof Liezel Massyn, Associate Professor in the UFS Business School, and Prof Kristina Areskoug Josefsson, Professor in Work-integrated Learning and Health Science from University West. They have a mutual commitment to improve educational practices through international partnerships and to advance integrated learning strategies. Together, they have already co-authored a research article and presented their findings at five conferences this year.

Prof Massyn said she realised that there is a need for work-integrated learning, specifically in the UFS Business School. “Initially, I thought our students were working, so they didn't need the work-integrated learning component. I then realised it could actually add a lot more value.”

Prof Nicolene Barkhuizen, Director of the UFS Business School, highlighted how this venture aligns with the university’s Vision 130, which aims to expand the UFS’ global footprint. “This partnership is an optimisation of the collaboration to contribute to Vision 130, expanding our reach globally while bringing practical value locally. We are looking forward to a very fruitful collaboration,” she said.

Speaking on behalf of the Faculty of Economic and Management Sciences, acting Dean Prof Frans Prinsloo discussed the potential for future projects. “Now that we have this collaboration agreement, there are many opportunities we can explore further,” he stated.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept